120 related articles for article (PubMed ID: 28123609)
1. Low Incidence along with Low mRNA Levels of
Peciak J; Stec WJ; Treda C; Ksiazkiewicz M; Janik K; Popeda M; Smolarz M; Rosiak K; Hulas-Bigoszewska K; Och W; Rieske P; Stoczynska-Fidelus E
J Cancer; 2017; 8(1):146-151. PubMed ID: 28123609
[No Abstract] [Full Text] [Related]
2. EGFR
Rutkowska A; Stoczyńska-Fidelus E; Janik K; Włodarczyk A; Rieske P
J Oncol; 2019; 2019():1092587. PubMed ID: 32089685
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance.
Aldape KD; Ballman K; Furth A; Buckner JC; Giannini C; Burger PC; Scheithauer BW; Jenkins RB; James CD
J Neuropathol Exp Neurol; 2004 Jul; 63(7):700-7. PubMed ID: 15290895
[TBL] [Abstract][Full Text] [Related]
4. Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in
Felsberg J; Hentschel B; Kaulich K; Gramatzki D; Zacher A; Malzkorn B; Kamp M; Sabel M; Simon M; Westphal M; Schackert G; Tonn JC; Pietsch T; von Deimling A; Loeffler M; Reifenberger G; Weller M;
Clin Cancer Res; 2017 Nov; 23(22):6846-6855. PubMed ID: 28855349
[No Abstract] [Full Text] [Related]
5. Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development.
Koga T; Li B; Figueroa JM; Ren B; Chen CC; Carter BS; Furnari FB
Neuro Oncol; 2018 Sep; 20(10):1310-1320. PubMed ID: 29660021
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.
Schulte A; Günther HS; Martens T; Zapf S; Riethdorf S; Wülfing C; Stoupiec M; Westphal M; Lamszus K
Clin Cancer Res; 2012 Apr; 18(7):1901-13. PubMed ID: 22316604
[TBL] [Abstract][Full Text] [Related]
7. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
Blehm KN; Spiess PE; Bondaruk JE; Dujka ME; Villares GJ; Zhao YJ; Bogler O; Aldape KD; Grossman HB; Adam L; McConkey DJ; Czerniak BA; Dinney CP; Bar-Eli M
Clin Cancer Res; 2006 Aug; 12(15):4671-7. PubMed ID: 16899617
[TBL] [Abstract][Full Text] [Related]
8. Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae.
Abulrob A; Giuseppin S; Andrade MF; McDermid A; Moreno M; Stanimirovic D
Oncogene; 2004 Sep; 23(41):6967-79. PubMed ID: 15273741
[TBL] [Abstract][Full Text] [Related]
9. Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy.
Weller M; Kaulich K; Hentschel B; Felsberg J; Gramatzki D; Pietsch T; Simon M; Westphal M; Schackert G; Tonn JC; von Deimling A; Davis T; Weiss WA; Loeffler M; Reifenberger G;
Int J Cancer; 2014 May; 134(10):2437-47. PubMed ID: 24614983
[TBL] [Abstract][Full Text] [Related]
10. Targeting EGFR in bladder cancer.
Villares GJ; Zigler M; Blehm K; Bogdan C; McConkey D; Colin D; Bar-Eli M
World J Urol; 2007 Dec; 25(6):573-9. PubMed ID: 17690890
[TBL] [Abstract][Full Text] [Related]
11. EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells.
Struve N; Riedel M; Schulte A; Rieckmann T; Grob TJ; Gal A; Rothkamm K; Lamszus K; Petersen C; Dikomey E; Kriegs M
Oncotarget; 2015 Oct; 6(32):33867-77. PubMed ID: 26418954
[TBL] [Abstract][Full Text] [Related]
12. Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma.
López-Ginés C; Navarro L; Muñoz-Hidalgo L; Buso E; Morales JM; Gil-Benso R; Gregori-Romero M; Megías J; Roldán P; Segura-Sabater R; Almerich-Silla JM; Monleón D; Cerdá-Nicolás M
Cell Oncol (Dordr); 2017 Aug; 40(4):389-399. PubMed ID: 28631186
[TBL] [Abstract][Full Text] [Related]
13. Defining EGFR amplification status for clinical trial inclusion.
French PJ; Eoli M; Sepulveda JM; de Heer I; Kros JM; Walenkamp A; Frenel JS; Franceschi E; Clement PM; Weller M; Ansell P; Looman J; Bain E; Morfouace M; Gorlia T; van den Bent M
Neuro Oncol; 2019 Oct; 21(10):1263-1272. PubMed ID: 31125418
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
Dziadziuszko R; Witta SE; Cappuzzo F; Park S; Tanaka K; Danenberg PV; Barón AE; Crino L; Franklin WA; Bunn PA; Varella-Garcia M; Danenberg KD; Hirsch FR
Clin Cancer Res; 2006 May; 12(10):3078-84. PubMed ID: 16707605
[TBL] [Abstract][Full Text] [Related]
16. Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
Savinainen KJ; Saramäki OR; Linja MJ; Bratt O; Tammela TL; Isola JJ; Visakorpi T
Am J Pathol; 2002 Jan; 160(1):339-45. PubMed ID: 11786427
[TBL] [Abstract][Full Text] [Related]
17. Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples.
Yoshimoto K; Dang J; Zhu S; Nathanson D; Huang T; Dumont R; Seligson DB; Yong WH; Xiong Z; Rao N; Winther H; Chakravarti A; Bigner DD; Mellinghoff IK; Horvath S; Cavenee WK; Cloughesy TF; Mischel PS
Clin Cancer Res; 2008 Jan; 14(2):488-93. PubMed ID: 18223223
[TBL] [Abstract][Full Text] [Related]
18. EGFR and EGFRvIII expression in primary breast cancer and cell lines.
Rae JM; Scheys JO; Clark KM; Chadwick RB; Kiefer MC; Lippman ME
Breast Cancer Res Treat; 2004 Sep; 87(1):87-95. PubMed ID: 15377854
[TBL] [Abstract][Full Text] [Related]
19. EGFRvIII--a stable target for anti-EGFRvIII therapy.
Banaszczyk M; Stoczynska-Fidelus E; Winiecka-Klimek M; Bienkowski M; Och W; Rieske P; Piaskowski S
Anticancer Res; 2013 Dec; 33(12):5343-8. PubMed ID: 24324068
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
Anticancer Res; 2001; 21(1A):189-95. PubMed ID: 11299733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
